Devenir des patients après découverte d’un granulome avec nécrose caseuse : une étude rétrospective observationnelle multicentrique (PECASGRA)
Year: 2024
Type: dissertation
Study design: Observational Study
Abstract: Introduction: Histological granulomas are associated with many diagnoses, including tuberculosis. This is a real diagnostic challenge, and the decision to impose a therapeutic sanction is significant because it is a very long treatment with highrisk of adverse effects. Methods: This was a retrospective multicenter study including patients who have been diagnosed a granuloma , without microbiological evidence, discussed in a mycobacteria consortium to decide management. The main objective of this study was to assess the proportion of patients treated with four or five drug regimens. The secondary objectives were to evaluate the predictive factors of the therapeutic decision and the outcome of patients according to the treatment decision. Results: From 2015 to 2023, 35 patients were included. Of these, 17 were treated. Factors associated with initiation of treatment were the persistence of a target lesion after histological sampling (p= 0.026), as well as presentation in the consortium before 2021 (p=0.044). The presence of immunosuppressive therapy (p=0.09), young age, were factors more in favor of treatment, and the presence of COPD was more associated with surveillance (p=0.09). Among treated patients, 1/3 were stable, 2/3 improved, two patients stopped their therapy early because of adverse effects. In the abstention group, 1/3 worsened radiologically and/or-clinically. Conclusion: The discovery of a granuloma with necrosis should require a complete etiological assessment. The introduction of a treatment is done on a case-by-case basis and should take into account the benefit/risk balance.
Source: HAL
Author: Deplaix, Chloé
Institution: Université de Picardie Jules Verne
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6981101554
